In Focus
Indonesia hikes healthcare spending by 8% to $12.84b
The country’s healthcare system remained unprepared to deal with the virus surge.
Indonesia hikes healthcare spending by 8% to $12.84b
The country’s healthcare system remained unprepared to deal with the virus surge.
Over 12 million e-prescriptions issued in Australia
Over 22,000 healthcare providers are now issuing e-prescriptions.
India’s non-profit hospitals face staff shortage
Some are struggling to recruit specialist doctors due to low salaries.
China to heighten competition for pharma exports to SSA
Nonetheless, India is still expected to be the region’s top supplier.
Chinese biopharmas eye collaboration with western firms
This could help them in promoting indigenous medicines.
China implements pharma patent reforms
It has introduced a patent term extension for drugs.
Four in five Australian telemedicine users keen to consult online again
Over nine in 10 used telemedicine for the first time during the pandemic.
UN urges stronger COVAX support for APAC
The international organisation is calling for countries with surplus COVID-19 vaccine doses to donate to COVAX.
Subdued economy dampens multinational pharmas’ growth in China
Opportunities for MNCs exist largely in generics and OTC segments.
APAC’s hospitals brace for patient backlogs
Australia faced higher wait times to between 240-365 days for elective surgeries.
India’s hospital industry enjoys high investment demand
Demand for health services is rising in Tier 2 and Tier 3 locations.
Chinese vaccines remain vital in developing nations despite criticisms
Developing nations face inadequate supply as developed nations stockpiled vaccines from top manufacturers.
What will drive India's healthcare investments in coming years?
Although the country has the largest youth population, its number of senior citizens are rising.
Strong state commitment boosts Hong Kong's healthcare sector
The government has allocated 15% of its 2021 budget to healthcare.
Singapore to revamp public health subsidy system
The basis for hospital subsidies will be changed to per capita household income.
Further investment urged for Western China's pharma sector
Human rights issues are seen to have discouraged investment in the region.
APAC's healthcare buyouts doubled to 156 deals in 2020
Deals in the biopharma sector tripled during the year.
Commentary
Evolving the Healthcare landscape in Singapore with Integrated Ambulatory Surgical Centres